BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+7.64%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.56B
AUM Growth
+$6.56B
(+0.3%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
183
New
22
Increased
65
Reduced
79
Closed
14
Top Buys
| 1 |
DexCom
DXCM
|
$42.5M |
| 2 |
Cooper Companies
COO
|
$31.6M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$17.8M |
| 4 |
SI-BONE Inc
SIBN
|
$16.6M |
| 5 |
Steris
STE
|
$16.5M |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$114M |
| 2 |
Intuitive Surgical
ISRG
|
$59.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$51.7M |
| 4 |
Evolent Health
EVH
|
$29.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Healthcare | 99.12% |
| 2 | Industrials | 0.77% |
| 3 | Technology | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
lululemon athletica
LULU
$24.2B
| – | – | -770 | Closed | -$394K |
|
177
iShares MSCI China ETF
MCHI
$7.91B
| – | – | -4,100 | Closed | -$167K |
|
178
Nike
NKE
$114B
| – | – | -3,400 | Closed | -$369K |
|
179
Supernus Pharmaceuticals
SUPN
$2.53B
| – | – | -15,100 | Closed | -$437K |
|
180
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.9B
| – | – | -3,900 | Closed | -$534K |
|
181
Zai Lab
ZLAB
$3.68B
| – | – | -135,000 | Closed | -$3.71M |
|
|
KRTX
182
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – | -6,100 | Closed | -$1.93M |
|
|
INBX
183
DELISTED
Inhibrx, Inc. Common Stock
INBX
| – | – | -24,600 | Closed | -$935K |
|